LRMR Larimar Therapeutics, Inc.
Fundamentals / CIK 0001374690 / USDLarimar Therapeutics, Inc. reported $140.5M in total assets and a net loss of $156.0M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LRMR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$161.9M Operating profit
-
Net Income FY 2025-$156.0M GAAP bottom line
-
Diluted EPS FY 2025-- Split-adjusted
-
Free Cash Flow FY 2025-$113.3M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$128.7M Total debt: $4.78M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- | $0 | $0 | $0 | $0 |
| Research & Development | $154.2M | $73.28M | $27.67M | $24.25M | $38.40M | $31.41M | $20.79M | $47.93M | $40.84M | $39.94M |
| Total Operating Expenses | $172.5M | $90.89M | $41.76M | $36.53M | $50.47M | $42.80M | $23.21M | $61.12M | $53.00M | $58.23M |
| Operating Income | -$172.5M | -$90.89M | -$41.76M | -$36.53M | -$50.47M | -$42.80M | -$23.21M | -$61.12M | -$53.00M | -$58.23M |
| EBITDA | -$172.1M | -$90.57M | -$41.45M | -$36.21M | -$50.14M | -$42.65M | -$23.14M | -$60.86M | -$52.81M | -$58.01M |
| Interest Income | -- | -- | -- | -- | -- | -- | $1.99M | $1.89M | $996K | -- |
| Interest Expense | -- | -- | -- | -- | -- | -- | $1.77M | $1.90M | $165K | $529K |
| Income Before Tax | -$165.7M | -$80.60M | -$36.95M | -$35.35M | -$50.64M | -$42.48M | -$23.18M | -$61.37M | -$52.03M | -$57.88M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$165.7M | -$80.60M | -$36.95M | -$35.35M | -$50.64M | -$42.48M | -$23.13M | -$61.37M | -$52.03M | -$57.88M |
| Basic EPS | -- | -$1.32 | -$0.84 | -$1.37 | -$2.95 | -$3.57 | -$3.80 | -$1.90 | -$1.90 | -$2.12 |
| Diluted EPS | -- | -$1.32 | -$0.84 | -$1.37 | -$2.95 | -$3.57 | -$3.80 | -$1.90 | -$1.90 | -$2.12 |
| Basic Shares Outstanding | -- | 61.3M | 43.9M | 25.8M | 17.2M | 11.9M | 6.1M | 32.2M | 27.4M | 27.3M |
| Diluted Shares Outstanding | -- | 61.3M | 43.9M | 25.8M | 17.2M | 11.9M | 6.1M | 32.2M | 27.4M | 27.3M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $25.93M | $28.00M | $25.03M | $59.37M | $44.93M | $23.37M | $26.55M | $26.74M |
| Total Operating Expenses | $32.46M | $34.35M | $31.12M | $64.02M | $49.50M | $27.79M | $31.19M | $31.29M |
| Operating Income | -$32.46M | -$34.35M | -$31.12M | -$64.02M | -$49.50M | -$27.79M | -$31.19M | -$31.29M |
| EBITDA | -$32.41M | -$34.29M | -$31.05M | -$63.93M | -$49.41M | -$27.70M | -$31.10M | -$31.22M |
| Income Tax Expense | -- | -- | -- | -- | $0 | $0 | -- | -- |
| Net Income | -$31.14M | -$32.78M | -$29.61M | -$62.50M | -$47.71M | -$26.18M | -$29.28M | -$28.82M |
| Basic EPS | -- | -- | -- | -- | -$0.61 | -$0.41 | -$0.46 | -- |
| Diluted EPS | -- | -- | -- | -- | -$0.61 | -$0.41 | -$0.46 | -- |
| Basic Shares Outstanding | -- | -- | -- | -- | 78.3M | 64.0M | 64.0M | -- |
| Diluted Shares Outstanding | -- | -- | -- | -- | 78.3M | 64.0M | 64.0M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $85.41M | $33.22M | $26.75M | $26.82M | $70.10M | $68.15M | $1.01M | $49.33M | $40.78M | $32.35M |
| Short-Term Investments | $51.44M | $150.2M | $60.04M | $91.60M | -- | $24.49M | $43.05M | $68.73M | $61.27M | $96.84M |
| Cash & Short-Term Investments | $136.9M | $183.5M | $86.80M | $118.4M | $70.10M | $92.64M | $70.30M | $118.1M | $102.1M | $129.2M |
| Total Current Assets | $142.0M | $195.3M | $90.17M | $120.7M | $72.20M | $97.95M | $4.75M | $121.3M | $104.9M | $130.9M |
| Property, Plant & Equipment, Net | $622K | $881K | $684K | $831K | $1.05M | $1.04M | $274K | $375K | $528K | $661K |
| Other Non-Current Assets | $523K | $596K | $659K | $638K | $669K | $419K | $90K | $57K | $57K | $61K |
| Total Non-Current Assets | $3.82M | $4.92M | $5.76M | $5.67M | $6.46M | $6.73M | $451K | $432K | $585K | $722K |
| Total Assets | $145.8M | $200.2M | $95.94M | $126.4M | $78.67M | $104.7M | $5.20M | $121.8M | $105.5M | $131.6M |
| Accounts Payable | $5.22M | $2.42M | $1.28M | $1.69M | $1.66M | $2.63M | $3.54M | $3.59M | $3.02M | $2.57M |
| Total Current Liabilities | $64.80M | $24.36M | $9.51M | $10.71M | $8.85M | $8.99M | $5.89M | $13.31M | $7.29M | $9.89M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | $14.54M | $20.00M | $20.00M | $3.18M |
| Total Non-Current Liabilities | $2.96M | $4.06M | $4.71M | $4.80M | $5.41M | $6.00M | $0 | $15.19M | $20.00M | $0 |
| Total Liabilities | $67.76M | $28.41M | $14.21M | $15.50M | $14.25M | $14.99M | $5.89M | $28.49M | $27.29M | $9.89M |
| Total Debt (incl. Leases) | $4.07M | $5.12M | $5.55M | $5.41M | $6.00M | $6.52M | $21.39M | $20.00M | $20.00M | $3.18M |
| Common Stock | $83K | $64K | $43K | $43K | $18K | $15K | $6.0K | $37K | $27K | $27K |
| Retained Earnings | -$434.8M | -$269.2M | -$188.6M | -$151.6M | -$116.2M | -$65.61M | -$23.13M | -$350.9M | -$289.6M | -$237.5M |
| Accumulated Other Comp. Income | $54K | $148K | $81K | -$31K | -- | $1.0K | $35K | -$33K | -$58K | -$80K |
| Total Stockholders' Equity | $78.08M | $171.8M | $81.72M | $110.9M | $64.41M | $89.69M | -$694K | $2.91M | $78.22M | $121.7M |
| Total Equity | $78.08M | $171.8M | $81.72M | $110.9M | $64.41M | $89.69M | -$694K | $2.91M | $78.22M | $121.7M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $76.99M | $92.69M | $177.9M | $85.41M | $90.14M | $20.59M | $21.13M | $33.22M |
| Short-Term Investments | $51.67M | $63.58M | $22.47M | $51.44M | $85.30M | $117.9M | $136.4M | $150.2M |
| Cash & Short-Term Investments | $128.7M | $156.3M | $200.4M | $136.9M | $175.4M | $138.5M | $157.5M | $183.5M |
| Total Current Assets | $136.2M | $160.7M | $205.0M | $142.0M | $183.2M | $145.6M | $165.5M | $195.3M |
| Property, Plant & Equipment, Net | $597K | $639K | $558K | $622K | $709K | $797K | $855K | $881K |
| Other Non-Current Assets | $457K | $480K | $504K | $523K | $542K | $561K | $582K | $596K |
| Total Non-Current Assets | $4.35M | $4.63M | $3.53M | $3.82M | $4.13M | $4.43M | $4.69M | $4.92M |
| Total Assets | $140.5M | $165.3M | $208.5M | $145.8M | $187.3M | $150.0M | $170.2M | $200.2M |
| Accounts Payable | $5.11M | $7.60M | $8.58M | $5.22M | $11.10M | $4.17M | $2.27M | $2.42M |
| Total Current Liabilities | $35.65M | $34.17M | $47.76M | $64.80M | $45.12M | $26.65M | $22.13M | $24.36M |
| Total Non-Current Liabilities | $3.39M | $3.75M | $2.72M | $2.96M | $3.20M | $3.48M | $3.77M | $4.06M |
| Total Liabilities | $39.04M | $37.92M | $50.48M | $67.76M | $48.31M | $30.13M | $25.90M | $28.41M |
| Total Debt (incl. Leases) | $4.78M | $4.96M | $3.78M | $4.07M | $4.35M | $4.61M | $4.87M | $5.12M |
| Common Stock | $104K | $103K | $103K | $83K | $86K | $64K | $64K | $64K |
| Retained Earnings | -$528.4M | -$497.2M | -$464.4M | -$434.8M | -$372.3M | -$324.6M | -$298.4M | -$269.2M |
| Accumulated Other Comp. Income | -$19K | -$12K | $6.0K | $54K | $66K | -$9.0K | $54K | $148K |
| Total Stockholders' Equity | $101.5M | $127.4M | $158.0M | $78.08M | $139.0M | $119.9M | $144.3M | $171.8M |
| Total Equity | $101.5M | $127.4M | $158.0M | $78.08M | $139.0M | $119.9M | $144.3M | $171.8M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$165.7M | -$80.60M | -$36.95M | -$35.35M | -$50.64M | -$42.48M | -$23.13M | -$61.37M | -$52.03M | -$57.88M |
| Depreciation & Amortization | $350K | $318K | $311K | $318K | $326K | $155K | $78K | $261K | $188K | $212K |
| Stock-Based Compensation | $7.00M | $8.80M | $7.62M | $6.62M | $5.47M | $2.16M | $129K | $9.63M | $8.30M | $10.11M |
| Change in Payables | $2.79M | $1.14M | -$403K | $26K | -$974K | -$3.29M | $2.63M | $432K | $448K | -$4.62M |
| Operating Cash Flow | -$113.2M | -$70.76M | -$33.46M | -$27.57M | -$42.10M | -$42.20M | -$22.70M | -$51.49M | -$43.78M | -$51.98M |
| Capital Expenditure | -$91K | -$515K | -$164K | -$100K | -$333K | -$62K | -$83K | -$108K | -$55K | -$660K |
| Free Cash Flow | -$113.3M | -$71.28M | -$33.62M | -$27.67M | -$42.44M | -$42.26M | -$22.78M | -$51.59M | -$43.84M | -$52.63M |
| Purchases of Investments | -$83.60M | -$227.9M | -$101.2M | -$133.6M | -$8.25M | -$24.49M | -$82.86M | -$117.1M | -$114.5M | -$136.5M |
| Investing Cash Flow | $100.3M | -$85.39M | $33.35M | -$90.96M | $24.17M | $17.09M | -$83K | -$6.87M | $35.65M | $51.45M |
| Common Stock Issued | $65.09M | $161.8M | -- | $75.26M | $19.89M | $75.59M | -- | $64.86M | -- | -- |
| Financing Cash Flow | $65.09M | $161.9M | $30K | $75.26M | $19.89M | $93.59M | $19.39M | $66.91M | $16.56M | -$2.71M |
| Net Change in Cash | $52.19M | $5.74M | -$76K | -$43.27M | $1.95M | $68.48M | -$3.39M | $8.55M | $8.43M | -$3.24M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$31.14M | -$32.78M | -$29.61M | -$62.50M | -$47.71M | -$26.18M | -$29.28M | -$28.82M |
| Depreciation & Amortization | $57K | $62K | $64K | $87K | $88K | $87K | $88K | $77K |
| Stock-Based Compensation | $2.17M | $2.15M | $1.98M | $1.56M | $1.78M | $1.83M | $1.83M | $2.41M |
| Change in Payables | -$2.48M | -$557K | $2.92M | -$5.83M | $6.90M | $1.87M | -$150K | $738K |
| Operating Cash Flow | -$31.19M | -$44.03M | -$44.61M | -$38.53M | -$28.75M | -$19.38M | -$26.54M | -$21.82M |
| Capital Expenditure | -- | -- | -- | $0 | -$23K | -$19K | -$49K | -- |
| Free Cash Flow | -- | -- | -- | -$38.53M | -$28.78M | -$19.40M | -$26.59M | -- |
| Purchases of Investments | -- | -- | -- | $0 | -$3.46M | -$27.64M | -$52.50M | -$38.62M |
| Investing Cash Flow | $12.43M | -$40.91M | $29.00M | $34.00M | $33.02M | $18.84M | $14.45M | $19.20M |
| Common Stock Issued | $3.05M | -$435K | $108.1M | -- | -- | -- | -- | -- |
| Financing Cash Flow | $3.05M | -$435K | $108.1M | -- | -- | -- | -- | $36K |
| Net Change in Cash | -$15.70M | -$85.38M | $92.50M | -$4.73M | $69.55M | -$539K | -$12.09M | -$2.58M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -212.2% | -46.9% | -45.2% | -31.9% | -78.6% | -47.4% | -- | -2106.0% | -66.5% | -47.5% |
| Return on Assets (ROA) | -113.6% | -40.3% | -38.5% | -28.0% | -64.4% | -40.6% | -444.8% | -50.4% | -49.3% | -44.0% |
| Current Ratio | 2.19x | 8.02x | 9.49x | 11.28x | 8.16x | 10.89x | 0.81x | 9.12x | 14.39x | 13.23x |
| Quick Ratio | 2.11x | 7.53x | 9.13x | 11.06x | 7.92x | 10.30x | 11.93x | 8.88x | 14.00x | 13.06x |
| Debt to Equity | 0.05x | 0.03x | 0.07x | 0.05x | 0.09x | 0.07x | -- | 6.86x | 0.26x | 0.03x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -153.8% | -135.5% | -105.0% | -212.2% | -94.9% | -83.3% | -66.0% | -46.9% |
| Return on Assets (ROA) | -111.0% | -104.4% | -79.6% | -113.6% | -70.5% | -66.5% | -56.0% | -40.3% |
| Current Ratio | 3.82x | 4.70x | 4.29x | 2.19x | 4.06x | 5.46x | 7.48x | 8.02x |
| Quick Ratio | 3.61x | 4.57x | 4.20x | 2.11x | 3.89x | 5.20x | 7.12x | 7.53x |
| Debt to Equity | 0.05x | 0.04x | 0.02x | 0.05x | 0.03x | 0.04x | 0.03x | 0.03x |